AIDS Alert Archives – February 1, 2006
February 1, 2006
View Issues
-
Racism, poverty, sexism all play a role in epidemic’s spread among black women
Black women in the United States had the highest new diagnosis rate of HIV/AIDS of any ethnic/gender group between 2001 and 2004, according to the latest data from the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. -
Some PIs have greater impact than others on heart disease
Recent research has highlighted the cardiovascular problems that some HIV patients have had while being treated with protease inhibitors (PIs), but its been difficult for physicians to determine exactly which drugs are causing the most trouble. -
Clinical reminder might assist physicians in deciding when to offer HIV testing
Investigators have developed a clinical reminder that provides clinicians with a simple guide to when its important to offer HIV testing to patients. -
Compliance Corner: Research helps identify those at risk for non-adherence
Behavioral compliance interventions typically are time-consuming and costly, but it might work more efficiently if clinicians quickly could identify the patients most in need of such assistance. -
HIV patients taking antiretrovirals should avoid garlic, St. John’s wort
Many people infected with HIV look to natural health products to supplement their conventional medical care, and clinicians, understandably, are concerned about drug interactions. -
Study of efavirenz over 96 weeks shows durability, efficacious regimen
Recent results from the Daily Antiretroviral Therapy (DART 1) trial show promising results for antiretroviral-naïve patients. -
FDA Notifications: FDA grants tentative approval to generic Nevirapine
The Food and Drug Administration (FDA), on Dec. 27, 2005, granted tentative approval, through an expedited procedure, to generic Nevirapine Oral Suspension, 50 mg/5 mL, manufactured by Aurobindo Pharma LTD., of Hyderabad, India.